For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Bioversys Ag

USPTO Granted Patents = 22

EPO Patents = 9

Forward Citations = 33

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Marc Gitzinger (10 out of 12 patents)

Erin M Duffy (9 out of 22 patents)

Ashoke Bhattacharjee (9 out of 34 patents)

4. Zoltan F Kanyo (9 out of 19 patents)

5. Glenn E Dale (8 out of 15 patents)

6. Sergio Lociuro (8 out of 9 patents)

7. Joseph A Ippolito (7 out of 16 patents)

8. Marilyne Bourotte (6 out of 6 patents)

9. Christian Kemmer (5 out of 8 patents)

10. Vincent Trebosc (5 out of 6 patents)

11. Stefano Biondi (3 out of 3 patents)

12. Esther Porras De Francisco (3 out of 3 patents)

13. Modesto Jesús Remuiñan-Blanco (3 out of 3 patents)

14. Benoit Deprez (3 out of 15 patents)

15. Nicolas Willand (3 out of 8 patents)

22 patents: Sort by Forward Citations

1. 12403133 - Rifabutin treatment methods, uses, and compositions (2025-09-02),

2. 12370184 - Antibiotic combination therapies (2025-07-29),

3. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),

4. 12257241 - Rifabutin treatment methods, uses, and compositions (2025-03-25),

5. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),

6. 12152031 - Biodefense agents (2024-11-26),

7. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),

8. 11969423 - Compounds (2024-04-30),

9. 11903934 - Rifabutin treatment methods, uses, and compositions (2024-02-20),

10. 11833139 - Rifabutin treatment methods, uses, and compositions (2023-12-05),

11. 11351158 - Rifabutin treatment methods, uses, and compositions (2022-06-07),

12. 11344537 - Rifabutin treatment methods, uses, and compositions (2022-05-31),

13. 11254689 - Compounds (2022-02-22),

14. 11253499 - Compounds (2022-02-22),

15. 11207305 - Antibiotic combination therapies (2021-12-28),

BIOVERSYS AG is a biotechnology company focused on developing novel small molecule drugs to combat drug-resistant bacterial infections. They utilize their proprietary drug discovery platform to identify and advance potential candidates. BIOVERSYS AG aims to address the global challenge of antibiotic resistance with innovative and effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#21 in Basel

#545 in Switzerland

#27,905 in the World

Basel, Switzerland

Bioversys Ag

Forward Citations = 33

35 inventors:

Marc Gitzinger (10 out of 12 patents)

Erin M Duffy (9 out of 22 patents)

Ashoke Bhattacharjee (9 out of 34 patents)

4. Zoltan F Kanyo (9 out of 19 patents)

5. Glenn E Dale (8 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…